William Meury's most recent trade in Incyte Corp. was a trade of 125,000 Performance Shares done . Disclosure was reported to the exchange on July 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Incyte Corp. | William Meury | Director, Chief Executive Officer, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2025 | 125,000 | 125,000 | - | - | Performance Shares | |
| Incyte Corp. | William Meury | Director, Chief Executive Officer, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2025 | 108,303 | 108,303 | - | - | Performance Shares | |
| Incyte Corp. | William Meury | Director, Chief Executive Officer, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2025 | 36,101 | 36,101 (0%) | 0% | 0 | Common Stock | |
| Incyte Corp. | William Meury | Director, Chief Executive Officer, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 110,630 | 110,630 | - | - | Employee Stock Option (right to buy) | |
| Syndax Pharmaceuticals Inc | William Meury | Director | 05 Feb 2025 | 25,000 | 90,000 (0%) | 0% | 0 | Common Stock | ||
| Karuna Therapeutics Inc | Meury William | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 38,688 | 38,688 | - | - | Restricted Stock Units | |
| Syndax Pharmaceuticals Inc | Meury William | Director | 07 Feb 2024 | 17,000 | 65,000 (0%) | 0% | 0 | Common Stock | ||
| Karuna Therapeutics Inc | Meury William | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 316.30 per share. | 28 Dec 2023 | 8,694 | 29,379 (0%) | 0% | 316.3 | 2,749,912 | Common Stock |
| Syndax Pharmaceuticals Inc | William Meury | Director | 02 Aug 2023 | 35,000 | 83,000 (0%) | 0% | 7.1 | 248,850 | Common Stock | |
| Syndax Pharmaceuticals Inc | William Meury | Director | 02 Aug 2023 | 35,000 | 0 | - | - | Stock Options (Right to buy) | ||
| Syndax Pharmaceuticals Inc | William Meury | Director | 02 Aug 2023 | 35,000 | 48,000 (0%) | 0% | 20.5 | 715,946 | Common Stock | |
| Syndax Pharmaceuticals Inc | William Meury | Director | 02 Aug 2023 | 24,000 | 0 | - | - | Stock Options (Right to buy) | ||
| Syndax Pharmaceuticals Inc | William Meury | Director | 02 Aug 2023 | 24,000 | 0 | - | - | Stock Options (Right to buy) | ||
| Syndax Pharmaceuticals Inc | William Meury | Director | 02 Aug 2023 | 24,000 | 48,000 (0%) | 0% | 20.5 | 490,913 | Common Stock | |
| Syndax Pharmaceuticals Inc | William Meury | Director | 02 Aug 2023 | 24,000 | 72,000 (0%) | 0% | 9.5 | 227,280 | Common Stock | |
| Syndax Pharmaceuticals Inc | William Meury | Director | 02 Aug 2023 | 24,000 | 48,000 (0%) | 0% | 20.5 | 490,951 | Common Stock | |
| Syndax Pharmaceuticals Inc | William Meury | Director | 02 Aug 2023 | 24,000 | 72,000 (0%) | 0% | 7.9 | 189,120 | Common Stock | |
| Syndax Pharmaceuticals Inc | William Meury | Director | 02 Feb 2023 | 16,000 | 48,000 (0%) | 0% | 0 | Common Stock | ||
| Karuna Therapeutics Inc | William Meury | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 63,065 | 63,065 | - | - | Stock Option (Right to Buy) | |
| Karuna Therapeutics Inc | William Meury | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 38,073 | 38,073 (0%) | 0% | 0 | Common Stock | |
| Syndax Pharmaceuticals Inc | William Meury | Director | 02 Feb 2022 | 16,000 | 32,000 (0%) | 0% | 0 | Common Stock | ||
| Syndax Pharmaceuticals Inc | William Meury | Director | 03 Feb 2021 | 16,000 | 16,000 (0%) | 0% | 0 | Common Stock |